home Latest News Here’s Why Investors Should Hold AngioDynamics Stock Now – Zacks.com

Here’s Why Investors Should Hold AngioDynamics Stock Now – Zacks.com

This post was originally published on this site

Here’s Why Investors Should Hold AngioDynamics Stock Now  Zacks.com

AngioDynamics’ (ANGO) gains from solid prospects in the NanoKnife platform. However, sluggishness in the Venous Insufficiency business is a headwind.